Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
19 Cards in this Set
- Front
- Back
barbiturates
|
acute effects: relaxtion, euphoria, sense of inhibition, sedaton, sleep
withdrawal:tremors, nasusea, vomiting, intense perspiring, confusion, convulsions, hallucinations, high fevers, increased heart rate -->resembles closely the withdrawal after chronic alcohol abuse. |
|
benziodiazepines
|
DIAZEpam (valium), cholirDIAZEpoxide, Xanax. more safe than barbiturates- absorbed slowly in blood stream, relaxation effects
|
|
Nonbenziodiazepine
|
Zolpidem (ambiem), EsZopiclone, (lunesta), Buspirone
|
|
patterns of inhalant abuse
|
associated mostly with young. PEER INFLUENCE. prevalant among children in South America (young as 8-9)
|
|
Chronic effects of inhalant abuse
|
restless, irritable, anxious
|
|
societal response to inhalant abuse
|
oil of mustard, national inhalant and poison awareness week
|
|
effects of amyl and butyl nitrates
|
lowers blood pressure, reflexive increase in heart rate, intense vasodilation
|
|
Pure Food and Drug Act 1906
|
purity and consistency, clearly and accurately identified
|
|
Federal Food, Drug, Cosmetics act 1938
|
drug and cosmetics: accurately identified, research studies to demonstrate safety
|
|
Dietary Supplements Health Education Act 1994
|
guidelines for marketing vitamins and herbal preparations
|
|
Tobacco Control Act 2009
|
FDA authority to regulate tobacco product
|
|
Phase of Drug Testing
|
1- experimental drug administered to healthy volunteers to check for side effects
2-experimental drug given to small population of patients who have the condition for which drug is poss. treatment 3- Exp. drug given to large pop. of patients, issues of safety, effectivenes, and dosage levels are finalized 4- possible adverse reactions to drug that is available to public are monitor by prescribing physicians |
|
R&D for new drug
|
about 70 million per drug, 30 B dollars per year in industry
|
|
SSRI
|
Selective Serotonin Reuptake Inhibitor- group of antidepressants that slow down reuptake of serotonin synapses in brain
|
|
Primary Prevention
|
Targets children before they start using, wide audience of all school chidlren, age at onset for drug taking is cricital: goal to prevent first use
|
|
Secondary Prevention
|
Targets those who are most "at risk" but not neccassarily using, or use is limited; narrow audience more specific goals: goal is to reduce or prevent further use
|
|
Tertiary Prevention
|
Target those who are currently abusing or addicted, smallest target intensive rehab goals: goal is to prevent continued use or relapse
|
|
Dual Diagnosis
|
treatment of both addiction and mental illness
|
|
Effective Prevention Models
|
Peer-refusal skills, anxiety and stress reduction, social skills and personal decision-making
|